Copyright Reports & Markets. All rights reserved.

Global Oligonucleotide Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Oligonucleotide Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Antisense/RNAi oligonucleotides
      • 1.4.3 Others
    • 1.5 Market by Application
      • 1.5.1 Global Oligonucleotide Therapeutics Market Share by Application (2014-2025)
      • 1.5.2 Neurological disorders
      • 1.5.3 Cancer
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Oligonucleotide Therapeutics Market Size
    • 2.2 Oligonucleotide Therapeutics Growth Trends by Regions
      • 2.2.1 Oligonucleotide Therapeutics Market Size by Regions (2014-2025)
      • 2.2.2 Oligonucleotide Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Oligonucleotide Therapeutics Market Size by Manufacturers
      • 3.1.1 Global Oligonucleotide Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Oligonucleotide Therapeutics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Oligonucleotide Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Oligonucleotide Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Oligonucleotide Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Oligonucleotide Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Oligonucleotide Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Oligonucleotide Therapeutics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Oligonucleotide Therapeutics Market Size (2014-2019)
    • 5.2 Oligonucleotide Therapeutics Key Players in United States
    • 5.3 United States Oligonucleotide Therapeutics Market Size by Type
    • 5.4 United States Oligonucleotide Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Oligonucleotide Therapeutics Market Size (2014-2019)
    • 6.2 Oligonucleotide Therapeutics Key Players in Europe
    • 6.3 Europe Oligonucleotide Therapeutics Market Size by Type
    • 6.4 Europe Oligonucleotide Therapeutics Market Size by Application

    7 China

    • 7.1 China Oligonucleotide Therapeutics Market Size (2014-2019)
    • 7.2 Oligonucleotide Therapeutics Key Players in China
    • 7.3 China Oligonucleotide Therapeutics Market Size by Type
    • 7.4 China Oligonucleotide Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Oligonucleotide Therapeutics Market Size (2014-2019)
    • 8.2 Oligonucleotide Therapeutics Key Players in Japan
    • 8.3 Japan Oligonucleotide Therapeutics Market Size by Type
    • 8.4 Japan Oligonucleotide Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Oligonucleotide Therapeutics Market Size (2014-2019)
    • 9.2 Oligonucleotide Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Oligonucleotide Therapeutics Market Size by Type
    • 9.4 Southeast Asia Oligonucleotide Therapeutics Market Size by Application

    10 India

    • 10.1 India Oligonucleotide Therapeutics Market Size (2014-2019)
    • 10.2 Oligonucleotide Therapeutics Key Players in India
    • 10.3 India Oligonucleotide Therapeutics Market Size by Type
    • 10.4 India Oligonucleotide Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Oligonucleotide Therapeutics Market Size (2014-2019)
    • 11.2 Oligonucleotide Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Oligonucleotide Therapeutics Market Size by Type
    • 11.4 Central & South America Oligonucleotide Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Arrowhead Pharmaceuticals
      • 12.1.1 Arrowhead Pharmaceuticals Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Oligonucleotide Therapeutics Introduction
      • 12.1.4 Arrowhead Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2014-2019)
      • 12.1.5 Arrowhead Pharmaceuticals Recent Development
    • 12.2 GlaxoSmithKline
      • 12.2.1 GlaxoSmithKline Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Oligonucleotide Therapeutics Introduction
      • 12.2.4 GlaxoSmithKline Revenue in Oligonucleotide Therapeutics Business (2014-2019)
      • 12.2.5 GlaxoSmithKline Recent Development
    • 12.3 Ionis Pharmaceuticals
      • 12.3.1 Ionis Pharmaceuticals Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Oligonucleotide Therapeutics Introduction
      • 12.3.4 Ionis Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2014-2019)
      • 12.3.5 Ionis Pharmaceuticals Recent Development
    • 12.4 miRagen Therapeutics
      • 12.4.1 miRagen Therapeutics Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Oligonucleotide Therapeutics Introduction
      • 12.4.4 miRagen Therapeutics Revenue in Oligonucleotide Therapeutics Business (2014-2019)
      • 12.4.5 miRagen Therapeutics Recent Development
    • 12.5 Sarepta Therapeutics
      • 12.5.1 Sarepta Therapeutics Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Oligonucleotide Therapeutics Introduction
      • 12.5.4 Sarepta Therapeutics Revenue in Oligonucleotide Therapeutics Business (2014-2019)
      • 12.5.5 Sarepta Therapeutics Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Oligonucleotides are short nucleotides sequences of DNA or RNA molecules called oligomers. Oligonucleotide therapeutics target and inhibit the expression of certain diseases-causing genes, thus forming a new class of therapeutics to treat chronic diseases.
      In terms of geographic regions, the North Americas accounted for the major share in the antisense oligonucleotides market in 2017. The major reason for the market growth in this region is due to the increasing approval of products.
      In 2018, the global Oligonucleotide Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Oligonucleotide Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oligonucleotide Therapeutics development in United States, Europe and China.

      The key players covered in this study
      Arrowhead Pharmaceuticals
      GlaxoSmithKline
      Ionis Pharmaceuticals
      miRagen Therapeutics
      Sarepta Therapeutics
      ...

      Market segment by Type, the product can be split into
      Antisense/RNAi oligonucleotides
      Others

      Market segment by Application, split into
      Neurological disorders
      Cancer
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Oligonucleotide Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Oligonucleotide Therapeutics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Oligonucleotide Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now